Mirimus

0 followers


Mirimus' mission is to change the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Industries

Headquarters

NY, United States

Employees

51-200

Links

Org chart

Prem Premsrirut
Founder & CEO

Prem Premsrirut

Collapse
David Eads
Chief Financial Officer
Veronica Andrews
Chief People Officer
Sean Seibel
Chief Product & Technology Officer
James Connolly
Chief Sales Officer
Ana Vasileva
VP of Translational Research, Genomics, Cell & Molecular Biology
Hui-Ting Cheng
Head Scientist
Huaien Wang
Director of Cell-Based, Modeling, Cancer Biology & Genetics
Giuseppe Militello
Associate Director, RNAi Therapeutics
Michelle Riley
Project Manager